BC
AMTI

Burleson & Co’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

Burleson & Co’s Portfolio AMTI Stock Details AMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$3.96K Sell
9,416
-26,796
-74% -$27K ﹤0.01% 313
2022
Q3 		$35K Sell
36,212
-37,591
-51% -$66.4K 0.01% 210
2022
Q2 		$215K Hold
73,803
– – 0.05% 122
2022
Q1 		$555K Sell
73,803
-13,659
-16% -$113K 0.09% 101
2021
Q4 		$1.22M Sell
87,462
-26,815
-23% -$529K 0.18% 72
2021
Q3 		$2.96M Buy
114,277
+8,000
+8% +$254K 0.44% 40
2021
Q2 		$4.86M Sell
106,277
-400
-0.4% -$18.9K 0.71% 30
2021
Q1 		$4.7M Sell
106,677
-12,855
-11% -$625K 0.76% 25
2020
Q4 		$3.68M Buy
119,532
+1,142
+1% +$36.2K 0.64% 34
2020
Q3 		$3.52M Buy
118,390
+7,000
+6% +$172K 0.67% 34
2020
Q2 		$2.37M Buy
+111,390
New +$2.81M 0.52% 45

Other funds holding AMTI

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FFVM
Founders Fund VI Management San Francisco, California $45.8K AUM 58.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Burleson & Co's AMTI Position: Q4 2022 in Review

Burleson & Co reduced its Applied Molecular Transport Inc. Common Stock (AMTI) stake by 74% in Q4 2022, selling an estimated $27K and leaving 9,416 shares worth $3.96K. The position accounts for ﹤0.01% of the portfolio, ranked #313.

Burleson & Co first reported a position in AMTI in Q2 2020 and has held it in 11 quarters since. The position peaked at $4.86M in Q2 2021. 43 funds tracked by Wall St. Rank hold AMTI as of Q4 2022.

  • Burleson & Co held 9,416 shares of Applied Molecular Transport Inc. Common Stock worth $3.96K as of Q4 2022.
  • Burleson & Co sold 26,796 Applied Molecular Transport Inc. Common Stock shares in Q4 2022, an estimated $27K.
  • Applied Molecular Transport Inc. Common Stock made up ﹤0.01% of Burleson & Co's portfolio in Q4 2022, its #313 holding.
  • Burleson & Co first reported a position in Applied Molecular Transport Inc. Common Stock in Q2 2020 and has held it in 11 quarters since.
  • Burleson & Co's Applied Molecular Transport Inc. Common Stock position peaked at $4.86M in Q2 2021.
  • 43 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q4 2022.

Based on Burleson & Co's 13F filing for Q4 2022, filed 31 Jan 2023.